Newsfeeds - Spark Newswire

1 minute read

Today, 4:14 AM

Legend Biotech Corporation ("Legend Biotech" or the "Company") (NASDAQ:LEGN), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening

LEGN

2 minute read

News

Legend Biotech Announces Notification Of Delinquency From The Nasdaq Stock Market LLC

By Benzinga Newsdesk

Today, 4:14 AM

Legend Biotech Corporation ("Legend Biotech" or the "Company") (NASDAQ:LEGN), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening

LEGN

2 minute read

Analyst Ratings

4 Analysts Have This to Say About Legend Biotech

By Benzinga Insights

Today, 4:14 AM

Over the past 3 months, 4 analysts have published their opinion on Legend Biotech (NASDAQ:LEGN) stock. These analysts…

LEGN

1 minute read

Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims

By Vandana Singh

Today, 4:14 AM

HC Wainwright initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL) with a Buy rating and a price target of $6. The China-based company…

GRCL

1 minute read

JP Morgan Maintains Overweight on Legend Biotech, Raises Price Target to $65

By Benzinga Newsdesk

Today, 4:14 AM

JP Morgan analyst Jessica Fye maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and raises the price target from $61 to $65.

LEGN

1 minute read

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

By Benzinga Newsdesk

Today, 4:14 AM

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

LEGN

5 minute read

No Early Relief for JW Therapeutics from Cancer Wonder Drug

By The Bamboo Works

Today, 4:14 AM

Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down. Large-scale market expansion is not going to be easy The company is undervalued compared with its peers pending further progress in commercializing its products By Molly Wen

LEGN